World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Spring Sale: Get 35% off with a min. purchase of 2 titles. Use code SPRING35. Valid till 31st Mar 2025.

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Use of Enzyme Artificial Cells for Genetic Enzyme Defects that Increase Systemic Substrates to Toxic Levels

      https://doi.org/10.1142/9789812770370_0006Cited by:1 (Source: Crossref)
      Abstract:

      The following sections are included:

      • Introduction

        • General

        • Enzyme replacement therapy

      • Acatalasemia: Congenital Defect in the Enzyme Catalase

      • Preliminary Study on the Use of Catalase Artificial Cells to Replace Defective Catalase in Acatalasemia

        • Implantation of catalase artificial cells

        • Catalase artificial cells retained in a chamber for body fluid perfusion

      • In Vivo Kinetics of Catalase Artificial Cells for Acatalasemic Mice

        • Summary

        • Methods of preparation of catalase artificial cells and experimental procedures

        • Characteristics of acatalasemic mice

        • Kinetics of recovery of injected perborate

      • Immunological Studies on Catalase Artificial Cells in Acatalasemic Mice

        • Effects of immunizing doses of catalase solution and catalase artificial cells on antibody production

        • Permeability of membrane of collodion artificial cells to catalase antibody

        • Response of immunized acatalasemic mice to injections of catalase artificial cells or catalase solution

        • Appearance of catalase activity in the blood after injection of catalase solution or catalase artificial cells

      • Conclusion from Results of Basic Study Using the Acatalasemic Mice Model

      • Oral Xanthine Oxidase Artificial Cells in a Patient with Lesch-Nyhan Disease

        • Volume ratio of artificial cells/substrate solution

        • Effects of pH on enzyme activity

        • Patient with Lesch-Nyhan disease

      • Conclusion Based on Study

      • Phenylketonuria: Genetic Defect in Enzyme Phenylalanine Hydroxylase

        • Phenylketonuria

        • Enzyme replacement therapy

        • Oral PAL artificial cells for PKU based on novel theory of enterorecirculation of amino acids

      • Research Leading to Proposal of Enterorecirculation of Amino Acids

        • Classical theory of the main source of amino acids in the intestinal lumen

        • Research to test the classical theory

        • Animals on 24 h of protein-free diet

        • Results of study

        • Proposed theory of extensive enterorecirculation of amino acids

      • Oral Enzyme Artificial Cells for Genetic Enzyme Defects that Result in Elevated Systemic Amino Acid Levels

        • General design for study of use of oral PAL artificial cells in PKU rats

        • Methods of preparation ofcatalase artificial cells and experiment procedures

        • Phenylketonuria rat model

        • Intestinal phenylalanine

        • Plasma PHE levels in PKU rats

        • CSF cerebrospinal fluid in PKU rats

        • Growth as shown by body weight changes

        • Congenital PKU mice model

        • Summary discussion

        • Oral enzyme artificial cells to deplete other amino acids